Thyme Care announces EmblemHealth, Oak Street Health as partners
Thyme Care, a value-based cancer care navigation startup, announced several new strategic partners across the payer and provider spectrum. The startup,...
SCOTUS upholds Arkansas’ 340B drug pricing law
The U.S. Supreme Court refused to hear an appeal by a pharmaceutical industry group challenging Arkansas’ 340B drug pricing law....
UnitedHealth CEO acknowledges frustration with healthcare
In the days that followed the murder of UnitedHealthcare CEO Brian Thompson last week, many across the internet have unleashed...
Noom to begin offering oral medications for weight loss
Digital health company Noom is expanding its medication offerings to include oral drugs for weight loss, starting with metformin. Noom...
Walgreens in talks for sale to PE firm: WSJ
Walgreens is weighing a potential sale to a private equity firm, according to a report in The Wall Street Journal....
Future White House AI Czar Sacks likely to favor startups
Donald Trump has announced his intention to appoint venture capitalist and lawyer David O. Sacks to be “White House A.I....
A focus on executive security following UHC CEO’s death
“It couldn’t happen to me.” That’s a common refrain. But for the health insurance industry this week, the risk was...
Anthem faces backlash from new anesthesia policy, reverses course in all states
A recent decision from Anthem Blue Cross Blue Shield in three states to stop paying for anesthesia care in select...
Bristol Myers Squibb latest drug company to sue HHS over 340B rebate model
Bristol Myers Squibb became the latest large drugmaker to sue the federal government over a plan to change how it...
Are there lessons to be learned from primary care stumbles?
Just three years ago, primary care was a hot category with major players making sizeable investments to build out healthcare...
